- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2017-12-05 12:55:42
- Reporting Period:
- Accepted Time:
- 2017-12-05 12:55:42
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1501989||Cytomx Therapeutics Inc.||CTMX||Pharmaceutical Preparations (2834)||273521219|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1654058||A. Sean Mccarthy||C/o Cytomx Therapeutics, Inc. |
151 Oyster Point Blvd., Suite 400
South San Francisco CA 94080
|President And Ceo||Yes||Yes||No||No|
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Stock Option (right to buy)||Disposition||2017-12-01||4,100||$0.00||4,100||$0.95|
|Common Stock||Stock Option (right to buy)||Disposition||2017-12-01||10,240||$0.00||10,240||$1.13|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
Reported Non-Derivative Holdings
|Sec. Name||Remaning Holdings||Nature of Ownership||Explanation|
|Common Stock||158,737||Indirect||See footnote|
- 398 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.42 to $20.78, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Held in McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees.
- 100% of the shares subject to the option are fully vested and exercisable.